Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

Author:

Choueiri Toni K.1,Powles Thomas1,Peltola Katriina1,de Velasco Guillermo1,Burotto Mauricio1,Suarez Cristina1,Ghatalia Pooja1,Iacovelli Roberto1,Lam Elaine T.1,Verzoni Elena1,Gümüş Mahmut1,Stadler Walter M.1,Kollmannsberger Christian1,Melichar Bohuslav1,Venugopal Balaji1,Gross-Goupil Marine1,Poprach Alexandr1,De Santis Maria1,Schutz Fabio A.1,Park Se Hoon1,Nosov Dmitry A.1,Porta Camillo1,Lee Jae Lyun1,Garcia-del-Muro Xavier1,Biscaldi Elisa1,Manneh Kopp Ray1,Oya Mototsugu1,He Li1,Wang Aobo1,Perini Rodolfo F.1,Vickery Donna1,Albiges Laurence1,Rini Brian1

Affiliation:

1. From Dana–Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) — all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d´Hebron...

Funder

Merck

Publisher

Massachusetts Medical Society

Reference38 articles.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3